MedPath

Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department

Terminated
Conditions
Carbon Monoxide Poisoning
Anemia
Interventions
Device: Pulse Oximeter
Registration Number
NCT03017742
Lead Sponsor
Masimo Corporation
Brief Summary

The purpose of this study is to determine the clinical utility of triage screening for anemia and carbon monoxide poisoning (COP) in the ED setting.This is a prospective, nonrandomized, multi-center study of the performance of simultaneous non-invasive testing for two common disorders (COP and anemia). We will determine the limits of agreement and performance characteristics of non-invasive carboxyhemoglobin (SpCO) and hemoglobin (SpHb) values compared to standard blood tests for measurement of carboxyhemoglobin and hemoglobin, in the emergency department setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
813
Inclusion Criteria
  • Age 1 year or older.
  • At least one digit has acceptable width as measured by study-provided digit gauge.
  • Presenting to emergency department for any complaint.
  • Potential for IV catheter and/or blood draw for CBC as standard of care.
Exclusion Criteria
  • Patients unable to consent for any reason
  • Patients with fingernail polish, discoloration or trauma to fingers

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Test GroupPulse OximeterThe subjects enrolled in the test group will receive the pulse oximeter
Primary Outcome Measures
NameTimeMethod
SpCO Detection of Carbon Monoxide Poisoning (COP)up to 3 hours

Diagnostics performance of SpCO for detecting COP measured by sensitivity and specificity compared to COHb.

Utility of SpCO as a Screening Tool for Carbon Monoxide Poisoningup to 3 hours

Surveying healthcare providers whether SpCO screening lead to identification of occult toxicity

SpHb Utility for Screening Anemiaup to 3 hours

Establish SpHb threshold that predicts the clinical outcome for acute treatment of anemia

Carbon Monoxide (CO) Elimination Pharmacokinetics in Relation to Oxygen Administrationup to 3 hours

CO elimination will be evaluated as a function of administered oxygen.

Specificity of SpHb in Detecting Anemia.up to 3 hours

Specificity in detecting true non-anemic subjects as determined by co-oximeter reference analyzer.

Difference Between SpCO and COHbUp to 3 hours

Measure the difference between noninvasive carboxyhemoglobin (SpCO) and carboxyhemoglobin determined by co-oximeter measurement of blood (COHb) as calculated in terms of standard deviation.

The average difference between paired Masimo noninvasive carboxyhemoglobin (SpCO) and reference carboxyhemoglobin (COHb) determined by co-oximeter measurement of blood represented as mean bias.

Sensitivity of SpHb Detection of Anemia.up to 3 hours

Sensitivity in detecting true anemic subjects as determined by co-oximeter reference analyzer.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tepecik Training and Research Hospital IEC

🇹🇷

Izmir, Turkey

© Copyright 2025. All Rights Reserved by MedPath